Merck (MRK) Restructuring Costs (2009 - 2026)

Merck (MRK) has reported Restructuring Costs for 18 consecutive years, with $151.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Restructuring Costs fell 73.04% year-over-year to $151.0 million in Q2 2026; TTM through Jun 2026 was $606.0 million, a 17.66% decrease from a year earlier, with the FY2025 full-year figure at $889.0 million, up 187.7% from the prior year.
• Restructuring Costs was $151.0 million for Q2 2026 at Merck, down from $195.0 million in the prior quarter.
• Over five years, Restructuring Costs peaked at $560.0 million in Q2 2025 and troughed at $47.0 million in Q3 2025.
• A 5-year average of $137.9 million and a median of $108.5 million in 2022 frame the typical range for Restructuring Costs.
• Across the five-year window, Restructuring Costs tumbled 82.15% in 2022 and soared 600.0% in 2025, its largest moves.
• Over 5 years, Restructuring Costs stood at $49.0 million in 2022, then jumped by 420.41% to $255.0 million in 2023, then tumbled by 80.0% to $51.0 million in 2024, then soared by 317.65% to $213.0 million in 2025, then decreased by 29.11% to $151.0 million in 2026.
• The last three Restructuring Costs figures came in at $151.0 million (Q2 2026), $195.0 million (Q1 2026), and $213.0 million (Q4 2025), per Business Quant data.